Analysis of the application of methylprednisolone injection combined with ambroxol injection in the treatment of asthma

  • Rong Fan Jingzhou First People's Hospital
  • Wei Xiao Jingzhou First People's Hospital
  • Weihua Hu Jingzhou First People's Hospital
  • Zhu Wu Jingzhou First People's Hospital
DOI: https://doi.org/10.18686/aem.v12i2.386
Keywords: Asthma, Methylprednisolone, Ambroxol, Effect Observation

Abstract

Objective: To observe the effectiveness of different medication regimens in the treatment of asthma diseases. Methods: Sixty-four patients with asthma who attended the medical records department from 2020.6 to 2022.8 were analyzed. 32 patients in group A were treated with methylprednisolone alone, while group B was treated with intravenous amiloride injection in addition to the medication regimen in group A. The improvement time of symptoms in each group was observed, the total effective rate was calculated and the differences between groups were analyzed. Results: In Group B, the improvement time of wheeze, cough, croup and wet rales was earlier than that in Group A (P＜0.05). In terms of total effective rate, the difference was 65.63% vs. 93.75% in group A vs. group B (P < 0.05). Conclusion: The combination of methylprednisolone and ambroxol injection in the treatment of asthma can provide more rapid relief of symptoms and improve the efficacy, which is worth promoting.

References

[1] Sun MC. Treatment of 60 cases of bronchial asthma in the elderly with the combination of warm lung descending method and ambroxol hydrochloride glucose injection [J]. Chinese medicine research,2018,31(03):39-41.

[2] Li J. Effect of aminophenazone combined with aminophylline in the treatment of children with bronchial asthma[J]. Henan Medical Research,2019,28(17):3187-3188.

[3] Xu JW. Exploring the effect of aminophenazone hydrochloride in the treatment of pediatric asthma[J]. Contemporary Medicine Series,2017,15(23):114-115.
Published
2023-06-01
Issue
Vol 12, No 2 (2023)
Section
Original Research Article

Copyright (c) 2023 Rong Fan, Wei Xiao, Weihua Hu, Wu Zhu

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Authors submitting to USP journals agree to publish their manuscript under the Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC 4.0) where authors agree to allow third parties to share their work (copy, distribute, transmit) and to adapt it, under the condition that the authors are given credit, and that in the event of reuse or distribution, the terms of this license are made clear

Authors retain copyright of their work, with first publication rights (online and print) granted to Universe Scientific Publishing or the owner of the journal in question.